{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T20:47:36Z","timestamp":1791751656308,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.bone.2026.118124","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:23:59Z","timestamp":1790897039000},"page":"118124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Safety of alternating denosumab and zoledronic acid for osteonecrosis of the femoral head in children"],"prefix":"10.1016","volume":"214","author":[{"given":"Myra","family":"Poon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Vanderniet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie-Lee","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzie","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Sandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Biggin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig F.","family":"Munns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2026.118124_bb0005","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1302\/2046-3758.109.BJR-2021-0016.R1","article-title":"Osteoblast function in patients with idiopathic osteonecrosis of the femoral head","volume":"10","author":"Maestro-Paramio","year":"2021","journal-title":"Bone Jt. Res."},{"key":"10.1016\/j.bone.2026.118124_bb0010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/1471-2474-13-251","article-title":"Risk factors for revision of primary total hip arthroplasty: a systematic review","volume":"13","author":"Prokopetz","year":"2012","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.bone.2026.118124_bb0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/112070009800800209","article-title":"Natural history and conservative treatment of osteonecrosis (ON) of the femoral head","volume":"8","author":"Mazi\u00e8res","year":"1998","journal-title":"Hip Int."},{"key":"10.1016\/j.bone.2026.118124_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214855","article-title":"Risk factors for early revision after total hip and knee arthroplasty: national observational study from a surgeon and population perspective","volume":"14","author":"Bottle","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2026.118124_bb0025","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.orthres.2004.11.015","article-title":"Zoledronic acid improves femoral head sphericity in a rat model of perthes disease","volume":"23","author":"Little","year":"2005","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bone.2026.118124_bb0030","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.2106\/00004623-200708000-00009","article-title":"Intravenous bisphosphonate therapy for traumatic osteonecrosis of the femoral head in adolescents","volume":"89","author":"Ramachandran","year":"2007","journal-title":"J. Bone Jt. Surg."},{"key":"10.1016\/j.bone.2026.118124_bb0035","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1359\/jbmr.060905","article-title":"RANKL inhibition: a novel strategy to decrease femoral head deformity after ischemic osteonecrosis","volume":"21","author":"Kim","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.118124_bb0040","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.bone.2009.04.255","article-title":"Systemic effects of zoledronic acid in children with traumatic femoral head avascular necrosis and Legg\u2013Calve\u2013Perthes disease","volume":"45","author":"Johannesen","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bone.2026.118124_bb0045","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/pbc.24563","article-title":"Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: a retrospective analysis","volume":"60","author":"Padhye","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bone.2026.118124_bb0050","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1038\/s41598-024-54685-7","article-title":"The efficacy of Denosumab in the treatment of femoral head osteonecrosis: a retrospective comparative study","volume":"14","author":"Moon","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bone.2026.118124_bb0055","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/os.13584","article-title":"Denosumab can prevent collapse in patients with early-stage steroid-induced osteonecrosis of the femoral head by inhibiting osteoclasts and autophagy","volume":"15","author":"Liu","year":"2023","journal-title":"Orthop. Surg."},{"key":"10.1016\/j.bone.2026.118124_bb0060","first-page":"76","article-title":"Hypercalcemia and hypercalciuria during denosumab treatment in children with osteogenesis imperfecta type VI","volume":"18","author":"Trejo","year":"2018","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.bone.2026.118124_bb0065","article-title":"Hypercalcemia following discontinuation of denosumab therapy: a systematic review","volume":"15","author":"Horiuchi","year":"2021","journal-title":"Bone Rep."},{"key":"10.1016\/j.bone.2026.118124_bb0070","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/pedi.13367","article-title":"Childhood type 1 diabetes is associated with abnormal bone development","volume":"23","author":"Vora","year":"2022","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.bone.2026.118124_bb0075","first-page":"10460","article-title":"Expression of osteoprotegerin, RNAK and RANKL genes in femoral head avascular necrosis and related signaling pathway","volume":"8","author":"Miao","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bone.2026.118124_bb0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11420-016-9505-9","article-title":"Treatment of pre-collapse stages of osteonecrosis of the femoral head: a systematic review of randomized control trials","volume":"12","author":"Villa","year":"2016","journal-title":"HSS J."},{"key":"10.1016\/j.bone.2026.118124_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17453674.2017.1298020","article-title":"Denosumab and surgery for the treatment of Perthes\u2019 disease in a 9-year-old boy: favorable course documented by comprehensive imaging\u2014 a case report","volume":"88","author":"Meiss","year":"2017","journal-title":"Acta Orthop."},{"key":"10.1016\/j.bone.2026.118124_bb0090","article-title":"Denosumab-induced rebound hypercalcemia treated with bisphosphonates in a pediatric patient","volume":"1","author":"Gandolfi","year":"2023","journal-title":"JCEM Case Rep."},{"key":"10.1016\/j.bone.2026.118124_bb0095","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/jcm10010152","article-title":"Denosumab discontinuation and the rebound phenomenon: a narrative review","volume":"10","author":"Anastasilakis","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bone.2026.118124_bb0100","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3390\/jcm7120479","article-title":"Efficacy and safety of denosumab therapy for osteogenesis imperfecta patients with osteoporosis\u2014case series","volume":"7","author":"Kobayashi","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bone.2026.118124_bb0105","first-page":"24","article-title":"Safety and efficacy of denosumab in children with osteogenesis imperfect\u2014a first prospective trial","volume":"16","author":"Hoyer-Kuhn","year":"2016","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.bone.2026.118124_bb0110","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1210\/clinem\/dgad732","article-title":"Safety and efficacy of denosumab in children with osteogenesis imperfecta\u2014the first prospective comparative study","volume":"109","author":"Liu","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2026.118124_bb0115","doi-asserted-by":"crossref","first-page":"470","DOI":"10.21037\/tp-22-276","article-title":"Denosumab in pediatric bone disorders and the role of RANKL blockade: a narrative review","volume":"12","author":"Wang","year":"2023","journal-title":"Transl. Pediatr."},{"key":"10.1016\/j.bone.2026.118124_bb0120","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2014-3072","article-title":"Effect of denosumab on the growing skeleton in osteogenesis imperfecta","volume":"99","author":"Hoyer-Kuhn","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2026.118124_bb0125","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00247-020-04651-y","article-title":"Dense sclerotic metaphyseal bands caused by denosumab therapy","volume":"50","author":"Dunnion","year":"2020","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.bone.2026.118124_bb0130","doi-asserted-by":"crossref","first-page":"256","DOI":"10.21037\/tp.2017.09.10","article-title":"Zoledronic acid in pediatric metabolic bone disorders","volume":"6","author":"Bowden","year":"2017","journal-title":"Transl. Pediatr."},{"key":"10.1016\/j.bone.2026.118124_bb0135","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bone.2007.05.002","article-title":"Acute phase response and mineral status following low dose intravenous zoledronic acid in children","volume":"41","author":"Munns","year":"2007","journal-title":"Bone"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226003509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226003509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T20:43:38Z","timestamp":1791751418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328226003509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":27,"alternative-id":["S8756328226003509"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2026.118124","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of alternating denosumab and zoledronic acid for osteonecrosis of the femoral head in children","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2026.118124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118124"}}